NDC 61269-410

ETOPOPHOS

Etoposide Phosphate

ETOPOPHOS is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by H2-pharma, Llc. The primary component is Etoposide Phosphate.

• Product ID: 61269-410_34466284-8d9f-4d2e-88a4-5ca30df0d743
• NDC: 61269-410
• Product Type: Human Prescription Drug
• Proprietary Name: ETOPOPHOS
• Generic Name: Etoposide Phosphate
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2009-06-01
• Marketing Category: NDA / NDA
• Application Number: NDA020457
• Labeler Name: H2-Pharma, LLC
• Substance Name: ETOPOSIDE PHOSPHATE
• Active Ingredient Strength: 100 mg/1
• Pharm Classes: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 61269-410-20

1 VIAL, SINGLE-DOSE in 1 CARTON (61269-410-20) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE

• Marketing Start Date: 2009-06-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 61269-410-20 [61269041020]

ETOPOPHOS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA020457
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2009-06-01

Drug Details

Active Ingredients

Ingredient	Strength
ETOPOSIDE PHOSPHATE	100 mg/1

Pharmacological Class

• Topoisomerase Inhibitor [EPC]
• Topoisomerase Inhibitors [MoA]
• Topoisomerase Inhibitor [EPC]
• Topoisomerase Inhibitors [MoA]

NDC Crossover Matching brand name "ETOPOPHOS" or generic name "Etoposide Phosphate"

NDC	Brand Name	Generic Name
0015-3404	ETOPOPHOS	etoposide phosphate
61269-410	ETOPOPHOS	etoposide phosphate